Advanced therapy medicinal products (ATMPs) represent a group of innovative pharmaceuticals that are increasingly gaining importance. It combines gene therapeutics, s...

Throughout the world, a key principle underpinning patent protection is that the scope of protection should depend on how the invention contributes to existing knowle...

Intelligent automation offers considerable potential for addressing the R&D productivity agenda, but how can life sciences firms exploit smart new digital options...

Over the last 10 years (2008–2017), the United States FDA approved a total of 320 new drugs. Of these, 249 were new chemical entities (NCE) or small molecules, about ...

Across the world, patients who once may have had little hope of survival are benefiting from the treatment efficacy and potentially curative potential of novel cell t...